FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

<p style="text-align:justify;"> <b>Background:</b> Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Griffiths, G, Burns, S, Noble, S, Macbeth, F, Cohen, D, Maughan, T
Formato:	Journal article
Idioma:	English
Publicado em:	BioMed Central 2009

Registros relacionados

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
por: Macbeth, F, et al.
Publicado em: (2009)

FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in<sup>® </sup><b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
por: Macbeth Fergus R, et al.
Publicado em: (2009-10-01)

Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
por: Dong Qian, et al.
Publicado em: (2015-01-01)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado em: (2017)

Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial
por: Sadhna Kannan, et al.
Publicado em: (2021-03-01)

Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
por: Masahide Oki, et al.
Publicado em: (2024-12-01)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)
por: Sébastien Thureau, et al.
Publicado em: (2021-02-01)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
por: Staffurth John N, et al.
Publicado em: (2011-10-01)

The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
por: Lesley Sinclair, et al.
Publicado em: (2020-02-01)

Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy
por: Line Bjerregaard Stick, et al.
Publicado em: (2021-03-01)

Reporting of PPI and the MCID in phase III/IV randomised controlled trials—a systematic review
por: Joseph Brennan, et al.
Publicado em: (2023-05-01)

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
por: Colin I Tang, et al.
Publicado em: (2019-08-01)

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
por: Crosby, T, et al.
Publicado em: (2013)

A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial
por: Peter Langhorne, et al.
Publicado em: (2017-09-01)

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial
por: Msika Simon, et al.
Publicado em: (2011-07-01)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
por: Middleton, G, et al.
Publicado em: (2013)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).
por: Middleton, G, et al.
Publicado em: (2013)

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
por: Pascoe, S, et al.
Publicado em: (2016)

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
por: Yongjun Wang, et al.

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
por: Mukherjee, S, et al.
Publicado em: (2024)

Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial
por: Bruce C V Campbell, et al.

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
por: Hurt, C, et al.
Publicado em: (2017)

Trends in participant race and sex reporting in lung cancer phase III clinical trials
por: Faaiq N. Aslam, et al.
Publicado em: (2023-09-01)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
por: Garegrat, R, et al.
Publicado em: (2024)

Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol
por: Stephanie Stock, et al.
Publicado em: (2020-01-01)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
por: Peter Nash, et al.
Publicado em: (2019-06-01)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
por: Reema Garegrat, et al.
Publicado em: (2024-07-01)

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
por: Sabrina Sidali, et al.
Publicado em: (2023-07-01)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
por: Mukherjee, S, et al.
Publicado em: (2013)

Occupational support following arthroplasty of the lower limb (OPAL): trial protocol for a UK-wide phase III randomised controlled trial
por: Qi Wu, et al.
Publicado em: (2024-09-01)

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
por: Dean A. Fennell, et al.
Publicado em: (2018-04-01)

Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
por: Popov, I, et al.
Publicado em: (2008)

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
por: Dadasovich Ryan, et al.
Publicado em: (2009-04-01)

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
por: Wechsler, M, et al.
Publicado em: (2017)

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
por: Joseph Sexton, et al.
Publicado em: (2024-11-01)

AVOID; a phase III, randomised controlled trial using indocyanine green for the prevention of anastomotic leakage in colorectal surgery
por: Hein Putter, et al.
Publicado em: (2022-04-01)

Heartburn relief with bicarbonate-rich mineral water: results of the randomised, placebo-controlled phase-III trial STOMACH STILL
por: JOACHIM LABENZ, et al.
Publicado em: (2023-08-01)

Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
por: P. Falkai, et al.
Publicado em: (2023-03-01)

Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
por: Toni Choueiri
Publicado em: (2015-11-01)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
por: Forder Peta M, et al.
Publicado em: (2011-04-01)